Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024 Bod Science is plotting a capital raise and investigating new revenue streams as it reassured the […]
Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma by Martin Lane and Steve Jones May 23, 2023April 30, 2024
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Epsilon to end Valens deal as firm remains under financial strain by Steve Jones November 1, 2022April 29, 2024
Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare by Martin Lane September 22, 2022April 29, 2024
Epsilon future uncertain as half-year losses climb by 94% by Martin Lane September 1, 2022April 29, 2024
